Goldman Sachs Group Inc. has demonstrated a pronounced selling bias in recent months, with SEC Form 4 filings revealing $55.4 million in total sell transactions compared to just $45,926 in buys across 27 trades. The firm’s activity has centered on two tickers: SHCO and BACQ. Notably, on January 29, 2026, Goldman Sachs executed two large sales of SHCO shares, each valued at $14.99 million, accounting for the bulk of its recent sell-side volume. Meanwhile, BACQ saw sustained selling from late November through December 2025, with multiple transactions ranging from modest sums like $21.46 to more substantial amounts such as $35,706. The pattern suggests a strategic reduction in these positions, particularly in SHCO, where the twin January sales dwarf all other activity.
While selling dominates, Goldman Sachs did engage in limited buying, with 10 recent purchase transactions—all involving BACQ—though these were minor in scale, with values as low as $21.96 and none exceeding $16,200. The disparity between buy and sell volumes, particularly the concentrated SHCO disposals, points to a broader divestment trend. The absence of trades in other equities during this period further underscores the firm’s focus on unwinding these specific holdings. The data reflects a clear directional preference, with sales outpacing buys by a factor of over 1,200:1 in dollar terms.
AI-assisted summary